165 related articles for article (PubMed ID: 28126425)
21. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features.
Zhou H; Wang YX; Lou HY; Xu XJ; Zhang MM
Korean J Radiol; 2014; 15(2):218-25. PubMed ID: 24643319
[TBL] [Abstract][Full Text] [Related]
22. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Wu F; Yu J; Gan H; Zhang H; Tian D; Zheng D
Sci Rep; 2021 Nov; 11(1):21743. PubMed ID: 34741082
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.
Zhuge YZ; Wang Y; Zhang F; Zhu CK; Zhang W; Zhang M; He Q; Yang J; He J; Chen J; Zou XP
Liver Int; 2018 Oct; 38(10):1867-1874. PubMed ID: 29297975
[TBL] [Abstract][Full Text] [Related]
24. Hepatic veno-occlusive disease induced by Chinese medicinal herbs.
Mejías Manzano MLÁ; Giráldez Gallego Á; Serrano Jiménez M
Rev Esp Enferm Dig; 2017 Nov; 109(11):804. PubMed ID: 29032695
[TBL] [Abstract][Full Text] [Related]
25. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
Gao H; Li N; Wang JY; Zhang SC; Lin G
J Dig Dis; 2012 Jan; 13(1):33-9. PubMed ID: 22188914
[TBL] [Abstract][Full Text] [Related]
26. Human embryotoxicity of pyrrolizidine-containing drugs.
Huxtable RJ
Hepatology; 1989 Mar; 9(3):510-1. PubMed ID: 2921005
[No Abstract] [Full Text] [Related]
27. Hepatic veno-occlusive disease and drinking of herbal teas.
Sommer M
J Pediatr; 1989 Oct; 115(4):659-60. PubMed ID: 2610755
[No Abstract] [Full Text] [Related]
28. The Budd-Chiari syndrome and hepatic veno-occlusive disease. Recognition and treatment.
McDermott WV; Ridker PM
Arch Surg; 1990 Apr; 125(4):525-7. PubMed ID: 2322120
[TBL] [Abstract][Full Text] [Related]
29. Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin.
Rasenack R; Müller C; Kleinschmidt M; Rasenack J; Wiedenfeld H
Fetal Diagn Ther; 2003; 18(4):223-5. PubMed ID: 12835579
[TBL] [Abstract][Full Text] [Related]
30. Hepatotoxicity due to comfrey herb tea.
Ridker PN; McDermont WV
Am J Med; 1989 Dec; 87(6):701. PubMed ID: 2629737
[No Abstract] [Full Text] [Related]
31. Histological evaluation of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: Correlation with Drum Tower Severity Scoring.
Li R; Li L; Cai Z; Chen J; Zhang H; Zhao S; Tu J; Sun C; Jin Y; Zhang M; Zhang F; Zhang W; Yin Q; Xu H; Han H; Li T; Zhuge Y; Xiao J
Dig Liver Dis; 2024 Jul; 56(7):1220-1228. PubMed ID: 38151450
[TBL] [Abstract][Full Text] [Related]
32. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.
Jiang M; Wang L; Du X; Hao M; Gao P
J Int Med Res; 2020 Sep; 48(9):300060520961916. PubMed ID: 32993424
[TBL] [Abstract][Full Text] [Related]
33. Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique.
Zuckerman M; Steenkamp V; Stewart MJ
J Clin Pathol; 2002 Sep; 55(9):676-9. PubMed ID: 12194997
[TBL] [Abstract][Full Text] [Related]
34. Imaging features of hepatic sinusoidal obstruction syndrome or veno-occlusive disease in children.
Bohte AE; Dierselhuis MP; van Noesel MM; Lequin MH
Pediatr Radiol; 2022 Jan; 52(1):122-133. PubMed ID: 34729635
[TBL] [Abstract][Full Text] [Related]
35. Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome.
Yang X; Lei P; Song Y; Fei Z; Ai Y; Shang H; Bai T; Ye J; Li X
Eur J Radiol; 2021 May; 138():109632. PubMed ID: 33711570
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective multicenter cohort study.
Peng C; Zhang X; Zhang F; Liu L; Shao Y; Xiang X; Zhang W; Xiao J; Wang Y; Zhang B; Yin Q; Song Y; Mo Z; Zou X; Zhang M; Zhuge Y
Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1168-1178. PubMed ID: 31834055
[TBL] [Abstract][Full Text] [Related]
37. MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
Marasco G; Scaioli E; Renzulli M; Colecchia A; Golfieri R; Festi D; Bazzoli F; Digby RJ; Belluzzi A
Am J Gastroenterol; 2016 Jun; 111(6):767. PubMed ID: 27249976
[No Abstract] [Full Text] [Related]
38. [Hepatotoxicity of medicinal plants and plant-based preparations].
Pauwels A; Mostefa-Kara N
Gastroenterol Clin Biol; 1993; 17(5 Pt 2):H79-85. PubMed ID: 8243922
[No Abstract] [Full Text] [Related]
39. [Hepatic veno-occlusive disease associated with ingestion of Senecio tephrosioides].
Tomioka M; Calvo F; Siguas A; Sánchez L; Nava E; García U; Valdivia M; Reátegui E
Rev Gastroenterol Peru; 1995; 15(3):299-302. PubMed ID: 8580460
[TBL] [Abstract][Full Text] [Related]
40. Fatal pyrrolizidine alkaloid poisoning of infants caused by adulterated Senecio coronatus.
Van Schalkwyk FJ; Stander MA; Nsizwane M; Mathee A; Van Wyk BE
Forensic Sci Int; 2021 Mar; 320():110680. PubMed ID: 33461004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
